Detalles de la búsqueda
1.
Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registry.
Rheumatology (Oxford)
; 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934129
2.
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Rheumatology (Oxford)
; 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934120
3.
Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(9): 3614-3626, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962998
4.
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Rheumatology (Oxford)
; 61(12): 4875-4884, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285493
5.
Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis.
Mod Rheumatol
; 32(6): 1077-1085, 2022 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34915579
6.
Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Mod Rheumatol
; 31(1): 94-100, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32159414
7.
5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study.
Mod Rheumatol
; 30(5): 799-806, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31814496
8.
Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matching.
Clin Immunol
; 191: 67-74, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29614335
9.
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching.
Ann Rheum Dis
; 75(7): 1321-7, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26245754
10.
Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.
Mod Rheumatol
; 26(6): 850-856, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26873570
11.
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.
Ann Rheum Dis
; 74(2): 389-95, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24288014
12.
Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
Mod Rheumatol
; 24(3): 405-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24252016
13.
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
Mod Rheumatol
; 24(3): 399-404, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24252045
14.
Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model.
J Immunol
; 186(6): 3745-52, 2011 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21307293
15.
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Rheumatol Ther
; 10(6): 1705-1723, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856034
16.
Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes.
Arthritis Res Ther
; 24(1): 240, 2022 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303202
17.
Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease.
RMD Open
; 8(1)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260476
18.
Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study.
Arthritis Res Ther
; 24(1): 159, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768825
19.
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
Rheumatology (Oxford)
; 50(10): 1908-15, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21752873
20.
Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.
Mod Rheumatol
; 21(2): 184-91, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21052764